Skip to main content
Log in

Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma

  • Original article
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background

Studies have previously indicated that surgical outcomes are poorer for obese patients. To date, few reports concerning the effect of obesity on patient outcomes following a hepatectomy for hepatocellular carcinoma (HCC) have been published. The present study, therefore, sought to determine the impact of patients’ body mass index (BMI, kg/m2) on short- and long-term surgical outcomes and to identify potential prognostic factors for HCC following a hepatectomy.

Methods

Patient data was retrospectively collected from 181 consecutive patients between September 2002 and August 2007 who had undergone hepatectomy for HCC with curative intent. Patients were assigned to three groups according to their BMI (low <18.5, standard 18.5–25, and high >25), and the clinical and pathological data, surgical outcome, and long-term survival were analyzed and compared between the three groups.

Results

The overall survival rate of the low BMI group was notably below that of the standard group. Surgical outcomes were not significantly different between the three groups. Multivariate analysis revealed that a low BMI (<18.5) is a predictor of unfavorable prognosis.

Conclusions

The present study suggests that a low BMI is a significant prognostic factor for low overall survival when performing a hepatectomy for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Berkalp B, Cesur V, Corapcioglu D, Erol C, Baskal N. Obesity and left ventricular diastolic dysfunction. Int J Cardiol. 1995;52:23–6.

    Article  PubMed  CAS  Google Scholar 

  2. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655–60.

    PubMed  CAS  Google Scholar 

  3. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631–6.

    PubMed  CAS  Google Scholar 

  4. Wolk A, Gridley G, Svensson M, Nyren O, Mclaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21.

    Article  PubMed  CAS  Google Scholar 

  5. Lew EA, Garfinkle L. Variation in mortality by weight among 75,000 men and women. J Chronic Dis. 1979;32:563–76.

    Article  PubMed  CAS  Google Scholar 

  6. Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5.

    Article  PubMed  Google Scholar 

  7. Hawn MT, Bian J, Leeth RR, Ritchie G, Allen N, Bland KI, et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg. 2005;241:821–8.

    Article  PubMed  Google Scholar 

  8. Barry JD, Blackshaw GR, Edwards P, Lewis WG, Murphy P, Hodzovic I, et al. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma. Gastric Cancer. 2003;6:80–5.

    PubMed  Google Scholar 

  9. Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J. The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg. 2005;241:69–76.

    PubMed  Google Scholar 

  10. Tsujinaka T, Sasako M, Yamamoto S, Sano T, Kurokawa Y, Nashimoto A, et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007;14:355–61.

    Article  PubMed  Google Scholar 

  11. Inagawa S, Adachi S, Oda T, Kawamoto T, Koike N, Fukao K. Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer. 2000;3:141–4.

    Article  PubMed  Google Scholar 

  12. Yamanaka H, Nishi M, Kanemaki T, Hosoda N, Hioki K, Yamamoto M. Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients. JPEN. 1989;13:286–91.

    Article  CAS  Google Scholar 

  13. Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kasaoka C. Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology. 2003;50:284–8.

    PubMed  Google Scholar 

  14. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcome in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15:2164–72.

    Article  PubMed  Google Scholar 

  15. Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010;14:1285–91.

    Article  PubMed  Google Scholar 

  16. Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH. Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg. 2010;14:849–57.

    Article  PubMed  Google Scholar 

  17. Utsunomiya T, Okamoto M, Kameyama T, Matsuyama A, Yamamoto M, Fujiwara M, et al. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol. 2008;14:1553–8.

    Article  PubMed  Google Scholar 

  18. Caldwell SH, Crespo DM, Kang HS, AI-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:97–103.

    Article  Google Scholar 

  19. NIH Consensus Development. Conference: statement II health implications of obesity. Ann Intern Med. 1985;103:1073–7.

    Google Scholar 

  20. WHO. Obesity-preventing and managing the global epidemic. Report of WHO consultation on obesity. Geneva; 1997.

  21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.

    Article  PubMed  CAS  Google Scholar 

  22. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329–36.

    Article  PubMed  CAS  Google Scholar 

  23. Mukherjee M, Sahasrabuddhe MB. Effect of operation on peripheral lymphocyte counts and production of adenosine triphosphate (ATP) in cancer patients. J Surg Oncol. 1982;20:1–8.

    Article  PubMed  CAS  Google Scholar 

  24. Roth JA, Golub SH, Grimm EA, Eilber FR, Morton DL. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Surgery. 1976;79:46–51.

    PubMed  CAS  Google Scholar 

  25. Sobin LH, Wittekind CH (eds) TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 81–3.

  26. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;352:751–5.

    Google Scholar 

  27. Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst. 1985;74:319–23.

    PubMed  CAS  Google Scholar 

  28. Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW. Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981;67:785–9.

    PubMed  CAS  Google Scholar 

  29. Hansson LE, Baron J, Nyrén O, Bergström R, Wolk A, Lindgren A, et al. Early-life risk indicators of gastric cancer. A population based case-control study in Sweden. Int J Cancer. 1991;57:32–7.

    Article  Google Scholar 

  30. Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Masunaga R, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59:18–23.

    Article  PubMed  CAS  Google Scholar 

  31. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg. 2009;9:1636–42.

    Article  Google Scholar 

  32. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43:1295–302.

    Article  PubMed  Google Scholar 

  33. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008;47:1856–62.

    Article  PubMed  Google Scholar 

  34. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.

    Article  PubMed  Google Scholar 

  35. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322–6.

    Google Scholar 

  36. Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001;96:1243–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukiyasu Okamura.

About this article

Cite this article

Okamura, Y., Maeda, A., Matsunaga, K. et al. Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 19, 449–457 (2012). https://doi.org/10.1007/s00534-011-0461-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-011-0461-y

Keywords

Navigation